The 80th Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Educational Lecture

Educational Lecture 2-3F Tyrosine kinase inhibitor therapy discontinuation for chronic myelogenous leukemia to achieve clinical cure: current status and future perspectives

Sun. Oct 14, 2018 10:10 AM - 10:40 AM No.15 (Osaka International Convention Center, 7F 701-2)

Chair: Kazunori Onishi (Japanese Red Cross Tokai-Hokuriku Block Blood Center, Japan)

[EL2-3F] Tyrosine kinase inhibitor therapy discontinuation for chronic myelogenous leukemia to achieve clinical cure: current status and future perspectives

Takashi Kumagai (Deparment of Hematology, Ome Municipal General Hospital, Japan)